Marc de Perrot: Clinical Trials

2 trials sponsored by Marc de Perrot, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 21Unknown 1

Follow Marc de Perrot: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection
Durvalumab, Non-ablative oligofractionated radiation (NORT) - Lung Cancer Patients, Non-small Cell Lung Cancer (NSCLC)
Phase 2UnknownMarc de Perrot122024-05-222024-07-22
Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination
Radiation: Varying Doses of RT - Transplant-Related Lung Cancer
Not applicableRecruitingMarc de Perrot302021-04-282026-09-10

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)

Interventions

durvalumab (1)

Countries

Canada (2)